4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-20-010505
Director sold 2,434 shares at an average $295.22 ($718,574)
- Director acquired 12,278 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SHERWIN STEPHEN A Director | 2020-03-11 | Option exercise | +10,923 | $58.46 | $638,559 | 16,517 | D: show line 1 in the form |
| SHERWIN STEPHEN A Director | 2020-03-11 | Sale | −2,164 | $295.22 | $638,845 | 14,353 | D: show line 2 in the form |
| SHERWIN STEPHEN A Director | 2020-03-11 | Option exercise | +1,355 | $58.46 | $79,213 | 15,708 | D: show line 3 in the form |
| SHERWIN STEPHEN A Director | 2020-03-11 | Sale | −270 | $295.29 | $79,728 | 15,438 | D: show line 4 in the form |
| Open-market sales · 2,434 sh · avg $295.22 · $718,574 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| SHERWIN STEPHEN A Director | 2020-03-11 | Option exercise · Stock Option (Right to Buy) | −10,923 | 0 | D: show line 5 in the form | |||||
| SHERWIN STEPHEN A Director | 2020-03-11 | Option exercise · Stock Option (Right to Buy) | −1,355 | 0 | D: show line 6 in the form |
Loading xslF345X03/form4.xml…